Those engaging in physical activity, living in hot climates, or experiencing increased urination (common with hyperglycemia or SGLT2 inhibitor medications) require additional hydration beyond baseline recommendations
Florida Surgery & Weight Loss Center brings together experienced physicians and advanced practice providers specializing in obesity medicine, GLP-1 therapies, bariatric surgery, peptide therapy, and long-term wellness
Avoid stacking two peptides that act on the same receptor, and introduce only one new peptide per week to isolate side effects
Potential Benefits for Cardiovascular and Liver Health Phase 2 data showed reductions in liver fat content on MRI, relevant to MASLD, but dedicated cardiovascular outcomes trials have not yet been completed and cardiovascular benefits remain unconfirmed
Semaglutide GLP-1 is a weight management drug licensed by the FDA